What Does Genomics Tell Us About Patient Management?
In session I of iwAL 2018, Ari Melnick, MD, Torsten Haferlach, MD, and Klaus Metzeler, MD, discuss the role of genomics in managing patients with acute leukemias. The following e-learning webcasts cover topics on the epigenetic landscape in acute leukemias, the clinical implications of genetic and molecular characterization of AML, and epigenetic regulator mutations.
Presentations
Weill Cornell Medicine, New York City, NY
Ari Melnick, MD, from Weill Cornell Medicine, New York City, NY, talks about the epigenetic landscape in acute leukemias.
MLL Munich Leukemia Laboratory, Munich, Germany
Torsten Haferlach, MD, from MLL Munich Leukemia Laboratory, Munich, Germany, discusses the clinical implications of genetic and molecular characterization of AML.
LMU-University Hospital Munich, Munich, Germany
Klaus Metzeler, MD, of LMU-University Hospital Munich, Munich, Germany, presents a talk on mutations in epigenetic regulators.
